Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC

Summary

To evaluate the clinical effect of rapamycin combined with TACE on early-stage HCC with overexpression of ASPH after radical surgery using randomized controlled study and provide a new anti-recurrence treatment for HCC patients after operation.

Timeline

Start

2012-11

Primary completion

2015-06

Completion

2015-12

Drugs

Indications